药明生物(02269)因期权获行使而发行合计853.14万股

Group 1 - WuXi Biologics (02269) announced the issuance of a total of 8.5314 million ordinary shares as part of the exercise of options under its pre-IPO share option plan adopted on January 5, 2016, and revised on August 10, 2016 [1]